|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
50710456
???header.onlineuser??? :
489
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"egle d"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2022-04-15T02:35:15Z |
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
|
Gianni, L; CHIUN-SHENG HUANG; Egle, D; Bermejo, B; Zamagni, C; Thill, M; Anton, A; Zambelli, S; Bianchini, G; Russo, S; Ciruelos, E M; Greil, R; Semiglazov, V; Colleoni, M; Kelly, C; Mariani, G; Del Mastro, L; Maffeis, I; Valagussa, P; Viale, G |
| 國立臺灣大學 |
2016 |
Interim results from neoMONARCH: A neoadjuvant phase II study of abemaciclib in postmenopausal women with HR +/HER2-breast cancer (BC)
|
Hurvitz, S.; Abad, M. F.; Rostorfer, R.; Chan, D.; Egle, D.; Huang, C-S.; Barriga, S.; Costigan, T. M.; Caldwell, C. W.; Schilder, J. M.; Press, M. F.; Slamon, D.; Martin, M.; 黃俊升 |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
